Stocksigma LogoStocksigma Logo

Sandu Pharmaceuticals Reports Q2 FY27 Financial Results

For the quarter ended 30th Sep'26, Sandu Pharmaceuticals posted revenue from operations of ₹1,942.88 lakhs, up 10.26% YoY from ₹1,762.11 lakhs and 18.55%

Sandu Pharmaceuticals Reports Q2 FY27 Financial Results

Sandu Pharmaceuticals Ltd · Financial Result · 15 Nov 2026, 12:27 am

Sandu Pharmaceuticals Reports Q2 FY27 Financial Results For the quarter ended 30th Sep'26, Sandu Pharmaceuticals posted revenue from operations of ₹1,942.88 lakhs, up 10.26% YoY from ₹1,762.11 lakhs and 18.55% QoQ from ₹1,638.88 lakhs. Net profit rose 49.76% YoY to ₹78.52 lakhs versus ₹52.43 lakhs in the previous year quarter, with basic EPS increasing to ₹0.81 from ₹0.54. For the half-year ended 30th Sep'26, revenue stood at ₹3,581.76 lakhs compared to ₹3,432.01 lakhs YoY, while net profit grew 35.56% YoY to ₹101.35 lakhs from ₹74.76 lakhs.

Original exchange filing (PDF)

More announcements from Sandu Pharmaceuticals Ltd

All Sandu Pharmaceuticals Ltd announcements